These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 25483016)
1. HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV‑related hepatocellular carcinoma by targeting estrogen receptor-α. Chen JJ; Tang YS; Huang SF; Ai JG; Wang HX; Zhang LP Oncol Rep; 2015 Feb; 33(2):792-8. PubMed ID: 25483016 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. Zhang C; Liu P; Zhang C J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299 [TBL] [Abstract][Full Text] [Related]
5. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024 [TBL] [Abstract][Full Text] [Related]
7. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5. Xie X; Xu X; Sun C; Yu Z Biol Chem; 2018 May; 399(6):611-619. PubMed ID: 29604207 [TBL] [Abstract][Full Text] [Related]
9. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216 [TBL] [Abstract][Full Text] [Related]
10. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma. Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245 [TBL] [Abstract][Full Text] [Related]
11. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction. Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Gao F; Sun X; Wang L; Tang S; Yan C Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
15. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression. Zhao Q; Li T; Qi J; Liu J; Qin C PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640 [TBL] [Abstract][Full Text] [Related]
16. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma. Bai PS; Xia N; Sun H; Kong Y J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334 [TBL] [Abstract][Full Text] [Related]
17. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma. Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421 [TBL] [Abstract][Full Text] [Related]
20. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12. Yin D; Wang Y; Sai W; Zhang L; Miao Y; Cao L; Zhai X; Feng X; Yang L Oncol Rep; 2016 Oct; 36(4):2305-12. PubMed ID: 27571873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]